TransCode Therapeutics Inc. (RNAZ)

Last Closing Price: 2.06 (2026-09-01)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

TransCode Therapeutics Inc. (RNAZ) Revenue data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
Revenue
--
$-6.87M
--
--
$6.79M
$-6.79M
$0.04M
$-6.75M
$-6.75M
$-6.75M
$-6.75M
$-6.75M
$-6.75M
$-6.79M
$-6.77M
0.96M
0.96M
$-7.17
$-7.17
Balance Sheet Financials
$10.64M
$0.32M
$140.37M
$151.01M
$5.40M
--
$173.31M
$178.71M
$-27.70M
$-167.74M
$-27.69M
1.01M
Cash Flow Statement Financials
$-10.38M
--
$0.95M
$17.81M
$8.38M
$-9.43M
$0.00M
--
--
Fundamental Metrics & Ratios
1.97
--
--
--
-0.02
--
--
--
--
--
--
$-10.38M
--
--
--
--
--
--
--
24.37%
4.02%
-4.47%
24.37%
$-27.38
$-10.84
$-10.84